{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:54:18Z","timestamp":1791431658828,"version":"4.3.3"},"reference-count":30,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: This study aimed to investigate the relationship between Maresin-1 (MaR1), Chitinase-3-like protein 1 (CHI3L1), and inflammatory as well as hematological markers in patients with type 2 diabetes mellitus (T2DM) and diabetic nephropathy (DN). Materials and Methods: This cross-sectional study included 90 participants divided into three groups: healthy controls (n = 30), patients with T2DM (n = 30), and patients with diabetic nephropathy (n = 30). The serum levels of MaR1 and CHI3L1 were measured using ELISA. Biochemical and hematological parameters were also assessed. Statistical comparisons were conducted using non-parametric tests, and correlations were analyzed via Spearman correlation. Results: Serum MaR1 levels were significantly higher in DN patients compared to both T2DM patients and controls (p &lt; 0.01), while CHI3L1 levels were significantly lower in the DN group compared to controls (p = 0.007). MaR1 showed a positive correlation with CRP, BUN, and creatinine, and a negative correlation with GFR. CHI3L1 levels were positively correlated with GFR and negatively with BUN. Inflammatory markers such as CRP were elevated in the diabetic groups, while no significant differences were found in NLR values. Conclusions: Elevated MaR1 levels in DN patients and their correlation with renal dysfunction markers suggest that MaR1 may serve as a potential prognostic biomarker in diabetic nephropathy. The unexpected decrease in CHI3L1 levels in DN patients indicates the need for further research to clarify their role. These findings indicated that MaR1 and CHI3L1 should be further investigated in future studies as indicators for the early detection and monitoring of diabetic complications.<\/jats:p>","DOI":"10.3390\/medicina61071247","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T15:36:58Z","timestamp":1752161818000},"page":"1247","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Maresin 1 and CHI3L1 Levels Exhibit Opposing Trends and Correlations with Renal Dysfunction in Diabetic Nephropathy"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5792-3557","authenticated-orcid":false,"given":"Aykut","family":"Bulu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Fethi Sekin City Hospital, 23280 Elazig, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5395-0390","authenticated-orcid":false,"given":"Erhan","family":"Onalan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Firat University, 23119 Elazig, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2745-6561","authenticated-orcid":false,"given":"Burkay","family":"Yakar","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Firat University, 23119 Elazig, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulay","family":"Bulu","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Fethi Sekin City Hospital, 23280 Elazig, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senanur Onalan","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[{"name":"Department of Emergency, Elaz\u0131g Medikal Hospital, 23040 Elazig, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ferit","family":"Gursu","sequence":"additional","affiliation":[{"name":"Department of Biochem\u0131stry, Firat University, 23119 Elazig, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8529-9501","authenticated-orcid":false,"given":"Ugur","family":"Kaplankaya","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Firat University, 23119 Elazig, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2537-6023","authenticated-orcid":false,"given":"Emir","family":"Donder","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Firat University, 23119 Elazig, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1359-7358","authenticated-orcid":false,"given":"Tugce","family":"Kaymaz","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Nevsehir Hac\u0131 Bektas Veli University, 50100 Nevsehir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.12669\/pjms.35.6.1150","article-title":"Can hematological parameters in type 2 diabetes predict microvascular complication development?","volume":"35","author":"Onalan","year":"2019","journal-title":"Pak. J. Med. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.12659\/MSM.894774","article-title":"Platelet-to-Lymphocyte Ratio May Predict the Severity of Calcific Aortic Stenosis","volume":"21","author":"Akdag","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"ref_3","first-page":"11420","article-title":"Association of hematological indicies with diabetes, impaired glucose regulation and microvascular complications of diabetes","volume":"8","author":"Demirtas","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Saito-Sasaki, N., Sawada, Y., and Nakamura, M. (2022). Maresin-1 and Inflammatory Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031367"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2438247","DOI":"10.1155\/2017\/2438247","article-title":"Maresin 1 Mitigates High Glucose-Induced Mouse Glomerular Mesangial Cell Injury by Inhibiting Inflammation and Fibrosis","volume":"2017","author":"Tang","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000444855","article-title":"Chitinase 3 Like-1: An Emerging Molecule Involved in Diabetes and Diabetic Complications","volume":"83","author":"Malaguarnera","year":"2016","journal-title":"Pathobiology"},{"key":"ref_7","first-page":"2280","article-title":"Screening of key genes associated with m6A methylation in diabetic nephropathy patients by CIBERSORT and weighted gene coexpression network analysis","volume":"14","author":"Yin","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/jasmr.jasmr_35_20","article-title":"Correlation of serum chitinase-3-like protein 1 level with cardiovascular complications in Egyptian patients with type 2 diabetes mellitus","volume":"16","author":"Bazeed","year":"2021","journal-title":"J. Arab Soc. Med. Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2020). 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care, 43, S14\u2013S31.","DOI":"10.2337\/dc20-S002"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.2353\/ajpath.2010.100322","article-title":"Pro-resolving lipid mediators in health and disease","volume":"177","author":"Serhan","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7177889","DOI":"10.1155\/2022\/7177889","article-title":"Maresin 1 Alleviates Diabetic Kidney Disease via LGR6-Mediated cAMP-SOD2-ROS Pathway","volume":"2022","author":"Li","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_12","first-page":"2993","article-title":"Pro-resolving lipid mediators and mechanisms in the resolution of allergic airway inflammation","volume":"205","author":"Strickland","year":"2020","journal-title":"J. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"100120","DOI":"10.1016\/j.jlr.2021.100120","article-title":"Simultaneous analyses of urinary eicosanoids and related mediators identified tetranor-prostaglandin E metabolite as a novel biomarker of diabetic nephropathy","volume":"62","author":"Morita","year":"2021","journal-title":"J. Lipid Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41581-021-00454-y","article-title":"Pro-resolving lipid mediators: Regulators of inflammation, metabolism and kidney function","volume":"17","author":"Brennan","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/jcmm.16098","article-title":"Maresin 1 attenuates pro-inflammatory activation induced by \u03b2-amyloid and stimulates its uptake","volume":"25","author":"Wang","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"ref_16","first-page":"159","article-title":"YKL-40: A biomarker of inflammation and fibrosis in chronic disease","volume":"4","author":"Johansen","year":"2006","journal-title":"Clin. Med. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1475-2840-8-61","article-title":"YKL-40\u2014An emerging biomarker in cardiovascular disease and diabetes","volume":"8","author":"Rathcke","year":"2009","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-015-0287-z","article-title":"Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population","volume":"14","author":"Aguilera","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2337\/dc08-1144","article-title":"YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria","volume":"32","author":"Rathcke","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14017430802220567","article-title":"YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease","volume":"42","author":"Wang","year":"2008","journal-title":"Scand. Cardiovasc. J."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Thomsen, S.B., Gjesing, A.P., Rathcke, C.N., Ekstr\u00f8m, C.T., Eiberg, H., Hansen, T., Pedersen, O., and Vestergaard, H. (2015). Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0133672"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1086\/510438","article-title":"Functional variants in the promoter region of Chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia","volume":"80","author":"Zhao","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/jmedgenet-2013-101908","article-title":"Genetic variants in CHI3L1 influencing YKL-40 levels: Resequencing 900 individuals and genotyping 9000 individuals from the general population","volume":"50","author":"Kjaergaard","year":"2013","journal-title":"J. Med. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.imbio.2018.07.020","article-title":"YKL-40: A biomarker for early nephropathy in type 2 diabetic patients and its association with inflammatory cytokines","volume":"223","author":"Umapathy","year":"2018","journal-title":"Immunobiology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/geno.1997.4778","article-title":"Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family","volume":"43","author":"Rehli","year":"1997","journal-title":"Genomics"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diacare.27.3.813","article-title":"Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes","volume":"27","author":"Pickup","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Bulu, A., Onalan, E., Yakar, B., Bulu, G., Onalan Y\u0131ld\u0131r\u0131m, S., U\u011fur, K., and D\u00f6nder, E. (2025). Investigation of Inflammatory Markers in Patients with Polycystic Ovary Syndrome Receiving and Not Receiving Metformin Treatment. Medicina, 61.","DOI":"10.3390\/medicina61061012"},{"key":"ref_28","first-page":"76","article-title":"Predictive value of inflammatory and hematological data in diabetic and non-diabetic retinopathy","volume":"26","author":"Atli","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1590\/1806-9282.65.1.38","article-title":"Diabetes control could through platelet-to-lymphocyte ratio in hemograms","volume":"65","author":"Atak","year":"2019","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Neergaard-Petersen, S., Hvas, A.M., Grove, E.L., Larsen, S.B., Gregersen, S., and Kristensen, S.D. (2015). The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with Aspirin. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132629"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1247\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:07:48Z","timestamp":1760033268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["medicina61071247"],"URL":"https:\/\/doi.org\/10.3390\/medicina61071247","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]}}}